Topia Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 326.12%
- Profit Growth 200.13%
- Ebitda 291.57%
- Net Worth 30.69%
- Total Assets -16.65%
About Topia Life Sciences
Topia Life Sciences Private Limited (TLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 September 2012 and has a history of 12 years and four months. Its registered office is in Vadodara, Gujarat, India.
The Corporate was formerly known as Inclination Technologies Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hetalbahen Patel, Kamleshkumar Patel, and Rushang Patel serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U72900GJ2012PTC072101
-
Company No.
072101
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Sep 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Topia Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rushang Patel
|
Director | 25-Sep-2012 | Current |
|
Hetalbahen Patel
|
Director | 21-Sep-2024 | Current |
| Kamleshkumar Patel | Director | 21-Sep-2024 | Current |
Financial Performance of Topia Life Sciences.
Topia Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 326.12% increase. The company also saw a substantial improvement in profitability, with a 200.13% increase in profit. The company's net worth Soared by an impressive increase of 30.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Topia Life Sciences?
In 2022, Topia Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ombit Pharma Private LimitedHetalbahen Patel, Kamleshkumar Patel and 1 more are mutual person
-
Novumgen Private Limited
Hetalbahen Patel and Kamleshkumar Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Topia Life Sciences?
Topia Life Sciences has a workforce of 37 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Topia Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Topia Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
